Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children

Critical Care Medicine

Volumn 31, Issue 1, 2003, Pages 284-290

  Friedrich, Bernd ^a   Schmidt, Reinhold ^a   Reiss, Irwin ^a   Günther, Andreas ^a   Seeger, Werner ^a   Müller, Matthias ^a   Thul, Joseph ^a   Schranz, Dietmar ^a   Gortner, Ludwig ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b NONE

Author keywords

Cardiopulmonary bypass; Children; Phospholipids; SP B; SP C; Surface tension; Surfactant

Indexed keywords

FATTY ACID; LUNG SURFACTANT; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PROTEIN;

ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGERY; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE UNIT; LIPID COMPOSITION; LUNG ALVEOLUS SURFACE TENSION; MALE; PEDIATRIC SURGERY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; TRACHEA;

CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MALE; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; PULMONARY SURFACTANTS; STATISTICS, NONPARAMETRIC; SURFACE TENSION;

EID: 0037251565     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200301000-00045     Document Type: Article

References (48)

1. MacNaughton PD, Braude S, Hunter DN, et al: Changes in lung function and pulmonary capillary permeability after cardiopulmonary bypass. Crit Care Med 1992; 20:1289-1294
2. Messent M, Sinclair DG, Quinlan GJ, et al: Pulmonary vascular permeability after cardiopulmonary bypass and its relationship to oxidative stress. Crit Care Med 1997; 25:425-429
3. Messent M, Sullivan K, Keogh BF, et al: Adult respiratory distress syndrome following cardiopulmonary bypass: Incidence and prediction. Anaesthesia 1992; 47:267-268
4. Royston D, Fleming JS, Desai JB, et al: Increased production of peroxidation products associated with cardiac operations. J Thorac Cardiovasc Surg 1986; 91:759-766
5. Allen BS, Ilbawi MN: Hypoxia, reoxygenation and the role of systemic leukodepletion in pediatric heart surgery. Perfusion 2001; 16(Suppl):19-29
6. McGiffin DC, Kirklin JK: Cardiopulmonary bypass, deep hypothermia and total circulatory arrest. In: Pediatric Cardiac Surgery. Maroudis EC, Backer CL (Eds). St. Louis, Mosby, 1994, pp 115-129
7. Butler J, Rocker GM, Westaby S, et al: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55:552-559
8. Serraf A, Sellak H, Herve P, et al: Vascular endothelium viability and function after total cardiopulmonary bypass in neonatal piglets. Am J Respir Crit Care Med 1999; 159:544-551
9. Hawgood S, Clements JA: Pulmonary surfactant and its apoproteins. J Clin Invest 1990; 86:1-6
10. Veldhuizen R, Nag K, Orgeig S, et al: The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1998; 1408:90-108
11. Günther A, Ruppert C, Schmidt R, et al: Surfactant alteration and replacement in acute respiratory distress syndrome. Respir Res 2001; 2:353-364
12. Hallman M, Spragg R, Harrell JH, et al: Evidence of lung surfactant abnormality in respiratory failure. J Clin Invest 1982; 70:673-683
13. Gregory TJ, Longmore WJ, Moxley MA, et al: Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88:1976-1981
14. Günther A, Siebert C, Schmidt R, et al: Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996; 153:176-184
15. Schmidt R, Meier U, Yabut-Perez M, et al: Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome (ARDS) and severe pneumonia. Am J Respir Crit Care Med 2001; 163:95-100
16. Pison U, Obertacke U, Seeger W, et al: Surfactant protein A (SP-A) is decreased in acute parenchymal lung injury associated with polytrauma. Eur J Clin Invest 1992; 22:712-718
17. Günther A, Schmidt R, Feustel A, et al: Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in the large surfactant aggregates - Experimental and clinical studies. Am J Respir Crit Care Med 1999; 159:244-251
18. Schmidt R, Steinhilber W, Ruppert C, et al: An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 2002; 165:470-474
19. Seeger W, Grube C, Günther A, et al: Surfactant inhibition by plasma proteins: Differential sensitivity of various surfactant preparations. Eur Respir J 1993; 6:971-977
20. Hallman M, Glumoff V, Ramet M: Surfactant in respiratory distress syndrome and lung injury. Comp Biochem Physiol A 2001; 129:287-294
21. McGowan FX, Ikegami M, del Nido PJ, et al: Cardiopulmonary bypass significantly reduces surface activity in children. J Thorac Cardiovasc Surg 1993; 106:968-977
22. Griese M, Wilnhammer C, Jansen S, et al: Cardiopulmonary bypass reduces pulmonary surfactant activity in infants. J Thorac Cardiovasc Surg 1999; 118:237-244
23. Marcatili S, Guarino C, Giannattasio A, et al: Alterations of the endoalveolar surfactant after surgery with extracorporeal circulation. Respiration 1990; 57:233-238
24. Paul DA, Greenspan JS, Davis DA, et al: The role of cardiopulmonary bypass and surfactant in pulmonary decompensation after surgery for congenital heart disease. J Thorac Cardiovasc Surg 1999; 117:1025-1026
25. Veldhuizen R, Inchley K, Hearn SA, et al: Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates. Biochem J 1993; 295:141-147
26. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37:911-917
27. Rouser G, Fleischer S, Yamamoto A: Two-dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1970; 5:494-496
28. Krämer HJ, Schmidt R, Günther A, et al: ELISA technique for quantification of surfactant protein B (SP-B) in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1995; 152:1540-1544
29. Enhorning G: Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 1977; 43:198-203
30. Seeger W, Guenther A, Thede C: Differential sensitivity to fibrinogen inhibition of SP-Cvs. SP-B-based surfactants. Am J Physiol 1992; 262:L286-L291
31. Rady MY, Ryan T, Starr NJ: Early onset of acute pulmonary dysfunction after cardiovascular surgery: Risk factors and clinical outcome. Crit Care Med 1997; 25:831-839
32. Günther A, Schmidt R, Nix F, et al: Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur Respir J 1999; 14:565-573
33. Lewis JF, Ikegami M, Jobe AH: Altered surfactant function and metabolism in rabbits with acute lung injury. J Appl Physiol 1990; 69:2303-2310
34. Wright JR, Benson BJ, Williams MC, et al: Protein composition of rabbit alveolar surfactant subfractions. Biochim Biophys Acta 1984; 791:320-332
35. Fleming BD, Raynor CM, Keough KMW: Some characteristics of monolayers of 1-palmitoyl-2-oleoyl-phosphatidylglycerol with and without dipalmitoylphosphatidylcholine during dynamic compression and expansion. Biochim Biophys Acta 1983; 732:243-250
36. Greene KE, Wright JR, Steinberg KP, et al: Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999; 160:1843-1850
37. Wall NH, Royster RL: Pulmonary dysfunction after cardiopulmonary bypass: Should we ventilate the lungs on pump? Crit Care Med 2000; 28:1658-1660
38. Loer SA, Kalweit G, Tarnow J: Effects of ventilation and nonventilation on pulmonary venous blood gases and markers of lung hypoxia in humans undergoing total cardiopulmonary bypass. Crit Care Med 2000; 28:1336-1340
39. Matuschak GM: Pulmonary dysfunction after surgery involving cardiopulmonary bypass: Do we understand the mechanisms? Crit Care Med 1997; 25:1778-1780
40. Ikegami M, Jobe AH: Surfactant protein metabolism in vivo. Biochim Biophys Acta 1998; 1408:218-225
41. Gobran LI, Rooney SA: Regulation of SP-B and SP-C secretion in rat type II cells in primary culture. Am J Physiol 2001; 281:L1413-L1419
42. Anyanwu E, Dittrich H, Gieseking R, et al: Ultrastructural changes in the human lung following cardiopulmonary bypass. Basic Res Cardiol 1982; 77:309-322
43. Sugahara K, Iyama K, Sano K, et al: Overexpression of surfactant protein SP-A, SP-B and SP-C mRNA in rat lungs with lipopolysaccharide-induced injury. Lab Invest 1996; 74:209-220
44. White CW, Greene KE, Allen CB, et al: Elevated expression of surfactant proteins in newborn rats during adaptation to hyperoxia. Am J Respir Cell Mol Biol 2001; 25:51-59
45. Crim C, Longmore WJ: Sublethal hydrogen peroxide inhibits alveolar type II cell surfactant phospholipid biosynthetic enzymes. Am J Physiol 1995; 268:L129-L135
46. Haagsman HP, Diemel RV: Surfactant-associated proteins: Functions and structural variation. Comp Biochem Physiol A 2001; 129:91-108
47. Savani RC, Godinez RI, Godinez MH, et al: Respiratory distress after intratracheal bleomycin: Selective deficiency of surfactant proteins B and C. Am J Physiol 2001; 281:L685-L696
48. Notter RH, Wang Z, Egan EA, et al: Component-specific surface and physiological activity in bovine-derived lung surfactants. Chem Phys Lipids 2002; 114:21-34